• 
    

    
    

      99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

      腫瘤學(xué)

      2015-10-31 05:27:28
      關(guān)鍵詞:腫瘤學(xué)出版物來源

      腫瘤學(xué)

      來源出版物:Chinese Journal of Cancer, 2015, 34(3): 99-107聯(lián)系郵箱:Weidong Han, hanwdrsw@sina.com

      封面介紹:Cytokine-induced killer (CIK)cells are a heterogeneous cell population that was first discovered in the 1990s and can be generated from lymphocytes co-cultured with an anti-CD3 antibody and many other cytokines in vitro. Given the ongoing investigations of CIK cell-based ACI, this regimen has potentially widespread application prospects in the clinic for most types of cancer. CIK cells have become the main adoptive immunotherapeutic cells because of their particular biological characteristics and have been demonstrated to exert their therapeutic function in various malignancies except T-cell lymphoma. Additionally, numerous clinical trials have suggested that some existing regimens using CIK cells can enhance the clinical curative effects on malignant diseases. (The original cover art is provided by Yelei Guo and Weidong Han.)

      Cytokine-induced killer (CIK)cells: from basic research to clinical translation

      Yelei Guo, Weidong Han

      The accumulation of basic researches and clinical studies related to cytokine-induced killer (CIK)cells has confirmed their safety and feasibility in treating malignant diseases. Thisreview summarizes the available published literature related to the biological characteristics and clinical applications of CIK cells in recent years. A number of clinical trials with CIK cells have been implemented during the progressive phases of cancer, presenting potential widespread applications of CIK cells for the future. Furthermore, this review briefly compares clinical applications of CIK cells with those of other adoptive immunotherapeutic cells. However, at present, there are no uniform criteria or large-scale preparations of CIK cells. The overall clinical response is difficult to evaluate because of the use of autologous CIK cells. Based on these observations, several suggestions regarding uniform criteria and universal sources for CIK cell preparations and the use of CIK cells either combined with chemotherapy or alone as a primary strategy are briefly proposed in this review. Large-scale, controlled, grouped, and multi-center clinical trials on CIK cell-based immunotherapy should be conducted under strict supervision. These interventions might help to improve future clinical applications and increase the clinical curative effects of CIK cells for a broad range of malignancies in the future.

      Cytokine-induced killer cells; Immunotherapy; Antitumor effect; Cancer therapy; Clinical trials

      猜你喜歡
      腫瘤學(xué)出版物來源
      將來吃魚不用調(diào)刺啦
      試論《說文》“丵”字的來源
      “赤”的來源與“紅”在服裝中的應(yīng)用
      流行色(2018年11期)2018-03-23 02:21:22
      2017年出版物
      Global analyses of sea surface temperature, sea ice, and night marine air temperature since the latenineteenth century
      Arctic sea ice decline: Faster than forecast
      腫瘤學(xué)
      腫瘤學(xué)
      腫瘤學(xué)
      2015 年出版物
      隆安县| 蓬溪县| 政和县| 龙泉市| 壤塘县| 渭源县| 乌什县| 苗栗市| 凤城市| 塘沽区| 沿河| 江孜县| 耿马| 班玛县| 石嘴山市| 泽库县| 西充县| 武宣县| 临朐县| 铁岭县| 云林县| 墨竹工卡县| 台中县| 靖江市| 赞皇县| 谢通门县| 湖州市| 前郭尔| 乡城县| 湖南省| 金坛市| 宣汉县| 湖口县| 石狮市| 承德市| 平遥县| 浦江县| 塔河县| 马鞍山市| 英德市| 博乐市|